81200 Federal Register / Vol. 85, No. 241 / Tuesday, December 15, 2020 / Notices 

instructions for submitting comments. 

Do not submit electronically any 

information you consider to be 

Confidential Business Information (CBI) 

or other information whose disclosure is 

restricted by statute. 

• Mail: OPP Docket, Environmental 

Protection Agency Docket Center (EPA/ 

DC), (28221T), 1200 Pennsylvania Ave. 

NW, Washington, DC 20460–0001. 

• Hand Delivery: To make special 

arrangements for hand delivery or 

delivery of boxed information, please 

follow the instructions at http://

www.epa.gov/dockets/contacts.html. 

Due to the public health concerns 

related to COVID–19, the EPA Docket 

Center (EPA/DC) and Reading Room is 

closed to visitors with limited 

exceptions. The staff continues to 

provide remote customer service via 

email, phone, and webform. For the 

latest status information on EPA/DC 

services and docket access, visit https:// 

www.epa.gov/dockets. 

FOR FURTHER INFORMATION CONTACT: 

Marietta Echeverria, Registration 

Division (7505P), Office of Pesticide 

Programs, Environmental Protection 

Agency, 1200 Pennsylvania Ave. NW, 

Washington, DC 20460–0001; main 

telephone number: (703) 305–7090; 

email address: RDFRNotices@epa.gov. 

SUPPLEMENTARY INFORMATION: In 

accordance with the regulations at 40 

CFR 166.24(a)(1), EPA is soliciting 

public comment before making the 

decision whether or not to grant the 

exemption. 

I. General Information 

A. Does this action apply to me? 

You may be potentially affected by 

this action if you are an agricultural 

producer, food manufacturer, or 

pesticide manufacturer. The following 

list of North American Industrial 

Classification System (NAICS) codes is 

not intended to be exhaustive, but rather 

provides a guide to help readers 

determine whether this document 

applies to them. Potentially affected 

entities may include: 

• Crop production (NAICS code 111). 

• Animal production (NAICS code 

112). 

• Food manufacturing (NAICS code 

311). 

• Pesticide manufacturing (NAICS 

code 32532). 

B. What should I consider as I prepare 

my comments for EPA? 

1. Submitting CBI. Do not submit this 

information to EPA through 

www.regulations.gov or email. Clearly 

mark the part or all of the information 

that you claim to be CBI. For CBI 

information in a disk or CD–ROM that 

you mail to EPA, mark the outside of the 

disk or CD–ROM as CBI and then 

identify electronically within the disk or 

CD–ROM the specific information that 

is claimed as CBI. In addition to one 

complete version of the comment that 

includes information claimed as CBI, a 

copy of the comment that does not 

contain the information claimed as CBI 

must be submitted for inclusion in the 

public docket. Information so marked 

will not be disclosed except in 

accordance with procedures set forth in 

40 CFR part 2. 

2. Tips for preparing your comments. 

When preparing and submitting your 

comments, see the commenting tips at 

http://www.epa.gov/dockets/ 

comments.html. 

3. Environmental justice. EPA seeks to 

achieve environmental justice, the fair 

treatment and meaningful involvement 

of any group, including minority and/or 

low-income populations, in the 

development, implementation, and 

enforcement of environmental laws, 

regulations, and policies. To help 

address potential environmental justice 

issues, the Agency seeks information on 

any groups or segments of the 

population who, as a result of their 

location, cultural practices, or other 

factors, may have atypical or 

disproportionately high and adverse 

human health impacts or environmental 

effects from exposure to the pesticide(s) 

discussed in this document, compared 

to the general population. 

II. What Action is the Agency Taking? 

Under section 18 of the Federal 

Insecticide, Fungicide, and Rodenticide 

Act (FIFRA) (7 U.S.C. 136p), at the 

discretion of the EPA Administrator, a 

Federal or State agency may be 

exempted from any provision of FIFRA 

if the EPA Administrator determines 

that emergency conditions exist which 

require the exemption. The Washington 

State Department of Agriculture 

(WSDA) has requested the EPA 

Administrator to issue a specific 

exemption for the use of broflanilide 

(CAS No. 1207727–04–5) as a seed 

treatment on spring wheat to control 

wireworms. Information in accordance 

with 40 CFR part 166 was submitted as 

part of this request. 

As part of this request, the applicant 

stated that the currently registered 

products do not provide adequate 

control of wireworms, which are having 

a devastating and severe impact upon 

wheat fields and growers, especially in 

the dryland wheat growing counties of 

eastern Washington. Approximately 

1,029 lbs. of the active ingredient 

broflanilide would be needed for this 

emergency exemption program. 

Additional information regarding the 

critical need for the emergency and the 

proposed use pattern can be found in 

the section 18 emergency exemption 

application request at http://

www.regulations.gov, under the docket 

number EPA–HQ–OPP–2020–0570. 

This notice does not constitute a 

decision by EPA on the application 

itself. The regulations governing FIFRA 

section 18 emergency exemptions 

require publication of a notice of receipt 

of an application for an emergency 

exemption if it proposes the use of a 

new chemical which has not been 

registered by EPA. Broflanilide is not 

currently registered. 

This notice provides an opportunity 

for public comment on this application. 

The Agency will review and consider all 

comments received during the comment 

period in determining whether to issue 

the specific exemption requested by 

WSDA. 

Authority: 7 U.S.C. 136 et seq. 

Dated: November 23, 2020. 

Marietta Echeverria, 

Acting Director, Registration Division, Office 

of Pesticide Programs. 

[FR Doc. 2020–27539 Filed 12–14–20; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPPT–2020–0077; FRL–10016– 

83] 

Certain New Chemicals; Receipt and 

Status Information for October 2020 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: EPA is required under the 

Toxic Substances Control Act (TSCA), 

as amended by the Frank R. Lautenberg 

Chemical Safety for the 21st Century 

Act, to make information publicly 

available and to publish information in 

the Federal Register pertaining to 

submissions under TSCA Section 5, 

including notice of receipt of a 

Premanufacture notice (PMN), 

Significant New Use Notice (SNUN) or 

Microbial Commercial Activity Notice 

(MCAN), including an amended notice 

or test information; an exemption 

application (Biotech exemption); an 

application for a test marketing 

exemption (TME), both pending and/or 

concluded; a notice of commencement 

(NOC) of manufacture (including 

import) for new chemical substances; 

and a periodic status report on new 

chemical substances that are currently 

Federal Register / Vol. 85, No. 241 / Tuesday, December 15, 2020 / Notices 81201 

under EPA review or have recently 

concluded review. This document 

covers the period from 10/01/2020 to 

10/31/2020. 

DATES: Comments identified by the 

specific case number provided in this 

document must be received on or before 

January 14, 2021. 

ADDRESSES: Submit your comments, 

identified by docket identification (ID) 

number EPA–HQ–OPPT–2020–0077, 

and the specific case number for the 

chemical substance related to your 

comment, by one of the following 

methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the online 

instructions for submitting comments. 

Do not submit electronically any 

information you consider to be 

Confidential Business Information (CBI) 

or other information whose disclosure is 

restricted by statute. 

• Mail: Document Control Office 

(7407M), Office of Pollution Prevention 

and Toxics (OPPT), Environmental 

Protection Agency, 1200 Pennsylvania 

Ave. NW, Washington, DC 20460–0001. 

• Hand Delivery: To make special 

arrangements for hand delivery or 

delivery of boxed information, please 

follow the instructions at http://

www.epa.gov/dockets/contacts.html. 

Due to the public health concerns 

related to COVID–19, the EPA Docket 

Center (EPA/DC) and Reading Room is 

closed to visitors with limited 

exceptions. The staff continues to 

provide remote customer service via 

email, phone, and webform. For the 

latest status information on EPA/DC 

services and docket access, visit https:// 

www.epa.gov/dockets. 

FOR FURTHER INFORMATION CONTACT: For 

technical information contact: Jim 

Rahai, Information Management 

Division (MC 7407M), Office of 

Pollution Prevention and Toxics, 

Environmental Protection Agency, 1200 

Pennsylvania Ave. NW, Washington, DC 

20460–0001; telephone number: (202) 

564–8593; email address: rahai.jim@

epa.gov. 

For general information contact: The 

TSCA-Hotline, ABVI-Goodwill, 422 

South Clinton Ave., Rochester, NY 

14620; telephone number: (202) 554– 

1404; email address: TSCA-Hotline@

epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. Executive Summary 

A. What action is the Agency taking? 

This document provides the receipt 

and status reports for the period from 

10/01/2020 to 10/31/2020. The Agency 

is providing notice of receipt of PMNs, 

SNUNs and MCANs (including 

amended notices and test information); 

an exemption application under 40 CFR 

part 725 (Biotech exemption); TMEs, 

both pending and/or concluded; NOCs 

to manufacture a new chemical 

substance; and a periodic status report 

on new chemical substances that are 

currently under EPA review or have 

recently concluded review. 

EPA is also providing information on 

its website about cases reviewed under 

the amended TSCA, including the 

section 5 PMN/SNUN/MCAN and 

exemption notices received, the date of 

receipt, the final EPA determination on 

the notice, and the effective date of 

EPA’s determination for PMN/SNUN/ 

MCAN notices on its website at: https:// 

www.epa.gov/reviewing-new-chemicalsunder-toxic-substances-control-act-tsca/ 

status-pre-manufacture-notices. This 

information is updated on a weekly 

basis. 

B. What is the Agency’s authority for 

taking this action? 

Under the Toxic Substances Control 

Act (TSCA), 15 U.S.C. 2601 et seq., a 

chemical substance may be either an 

‘‘existing’’ chemical substance or a 

‘‘new’’ chemical substance. Any 

chemical substance that is not on EPA’s 

TSCA Inventory of Chemical Substances 

(TSCA Inventory) is classified as a ‘‘new 

chemical substance,’’ while a chemical 

substance that is listed on the TSCA 

Inventory is classified as an ‘‘existing 

chemical substance.’’ (See TSCA section 

3(11).) For more information about the 

TSCA Inventory please go to: https://

www.epa.gov/tsca-inventory. 

Any person who intends to 

manufacture (including import) a new 

chemical substance for a non-exempt 

commercial purpose, or to manufacture 

or process a chemical substance in a 

non-exempt manner for a use that EPA 

has determined is a significant new use, 

is required by TSCA section 5 to 

provide EPA with a PMN, MCAN or 

SNUN, as appropriate, before initiating 

the activity. EPA will review the notice, 

make a risk determination on the 

chemical substance or significant new 

use, and take appropriate action as 

described in TSCA section 5(a)(3). 

TSCA section 5(h)(1) authorizes EPA 

to allow persons, upon application and 

under appropriate restrictions, to 

manufacture or process a new chemical 

substance, or a chemical substance 

subject to a significant new use rule 

(SNUR) issued under TSCA section 

5(a)(2), for ‘‘test marketing’’ purposes, 

upon a showing that the manufacture, 

processing, distribution in commerce, 

use, and disposal of the chemical will 

not present an unreasonable risk of 

injury to health or the environment. 

This is referred to as a test marketing 

exemption, or TME. For more 

information about the requirements 

applicable to a new chemical go to: 

http://www.epa.gov/oppt/newchems. 

Under TSCA sections 5 and 8 and 

EPA regulations, EPA is required to 

publish in the Federal Register certain 

information, including notice of receipt 

of a PMN/SNUN/MCAN (including 

amended notices and test information); 

an exemption application under 40 CFR 

part 725 (biotech exemption); an 

application for a TME, both pending 

and concluded; NOCs to manufacture a 

new chemical substance; and a periodic 

status report on the new chemical 

substances that are currently under EPA 

review or have recently concluded 

review. 

C. Does this action apply to me? 

This action provides information that 

is directed to the public in general. 

D. Does this action have any 

incremental economic impacts or 

paperwork burdens? 

No. 

E. What should I consider as I prepare 

my comments for EPA? 

1. Submitting confidential business 

information (CBI). Do not submit this 

information to EPA through 

regulations.gov or email. Clearly mark 

the part or all of the information that 

you claim to be CBI. For CBI 

information in a disk or CD–ROM that 

you mail to EPA, mark the outside of the 

disk or CD–ROM as CBI and then 

identify electronically within the disk or 

CD–ROM the specific information that 

is claimed as CBI. In addition to one 

complete version of the comment that 

includes information claimed as CBI, a 

copy of the comment that does not 

contain the information claimed as CBI 

must be submitted for inclusion in the 

public docket. Information so marked 

will not be disclosed except in 

accordance with procedures set forth in 

40 CFR part 2. 

2. Tips for preparing your comments. 

When preparing and submitting your 

comments, see the commenting tips at 

http://www.epa.gov/dockets/ 

comments.html. 

II. Status Reports 

In the past, EPA has published 

individual notices reflecting the status 

of TSCA section 5 filings received, 

pending or concluded. In 1995, the 

Agency modified its approach and 

streamlined the information published 

in the Federal Register after providing 

notice of such changes to the public and 

81202 Federal Register / Vol. 85, No. 241 / Tuesday, December 15, 2020 / Notices 

an opportunity to comment (See the 

Federal Register of May 12, 1995, (60 

FR 25798) (FRL–4942–7). Since the 

passage of the Lautenberg amendments 

to TSCA in 2016, public interest in 

information on the status of section 5 

cases under EPA review and, in 

particular, the final determination of 

such cases, has increased. In an effort to 

be responsive to the regulated 

community, the users of this 

information, and the general public, to 

comply with the requirements of TSCA, 

to conserve EPA resources and to 

streamline the process and make it more 

timely, EPA is providing information on 

its website about cases reviewed under 

the amended TSCA, including the 

section 5 PMN/SNUN/MCAN and 

exemption notices received, the date of 

receipt, the final EPA determination on 

the notice, and the effective date of 

EPA’s determination for PMN/SNUN/ 

MCAN notices on its website at: https:// 

www.epa.gov/reviewing-new-chemicalsunder-toxic-substances-control-act-tsca/ 

status-pre-manufacture-notices. This 

information is updated on a weekly 

basis. 

III. Receipt Reports 

For the PMN/SNUN/MCANs that 

have passed an initial screening by EPA 

during this period, Table I provides the 

following information (to the extent that 

such information is not subject to a CBI 

claim) on the notices screened by EPA 

during this period: The EPA case 

number assigned to the notice that 

indicates whether the submission is an 

initial submission, or an amendment, a 

notation of which version was received, 

the date the notice was received by EPA, 

the submitting manufacturer (i.e., 

domestic producer or importer), the 

potential uses identified by the 

manufacturer in the notice, and the 

chemical substance identity. 

As used in each of the tables in this 

unit, (S) indicates that the information 

in the table is the specific information 

provided by the submitter, and (G) 

indicates that this information in the 

table is generic information because the 

specific information provided by the 

submitter was claimed as CBI. 

Submissions which are initial 

submissions will not have a letter 

following the case number. Submissions 

which are amendments to previous 

submissions will have a case number 

followed by the letter ‘‘A’’ (e.g. P–18– 

1234A). The version column designates 

submissions in sequence as ‘‘1’’, ‘‘2’’, 

‘‘3’’, etc. Note that in some cases, an 

initial submission is not numbered as 

version 1; this is because earlier 

version(s) were rejected as incomplete 

or invalid submissions. Note also that 

future versions of the following tables 

may adjust slightly as the Agency works 

to automate population of the data in 

the tables. 

TABLE I—PMN/SNUN/MCANS APPROVED * FROM 10/01/2020 TO 10/31/2020 

Case No. Version Received 

date Manufacturer Use Chemical substance 

P–17–0301A .. 5 10/06/2020 CBI .............................. (G) Used as a surface drier in clear and pigmented coatings systems to replace other primary driers, particularly cobalt.(G) Manganese heterocyclic-amine carboxylate 

complexes. 

P–18–0175A .. 9 10/01/2020 Hexion Inc .................. (S) Food can coating Non-food contact can 

coating.

(S) Formaldehyde, polymer with 4-(1,1- 

dimethylethyl)phenol and phenol, Bu ether. 

P–18–0301A .. 2 10/01/2020 CBI .............................. (G) Coating component ....................................... (G) Alkanedioic acid, polymer with cycloalkyl 

dimethanol, alkyl and cycloalkyl diisocyanates, 

dimethyl-alkanediol, dihydroxyalkanoic acid 

methylenebis[isocyanatocyclohexane, hydroxyethyl acrylate- and polyalkyl glycol 

monoalkyl ether blocked. 

P–18–0349A .. 5 10/05/2020 Lanxess Solutions US, 

Inc.

(S) Two component adhesives and protective 

coatings for marine, infrastructure, etc. The 

urethane prepolymer is designed to react with 

epoxy materials to create a flexible coating or 

adhesive.

(S) Oxirane, 2-methyl-, polymer with oxirane, 

ether with 1,2,3-propanetriol (3:1), polymer 

with 2,4-diisocyanato-1-methylbenzene, 

branched 4-nonylphenol-blocked. 

P–18–0383A .. 4 10/01/2020 CBI .............................. (G) Coatings and inks for commercial use ......... (G) Dialkyl-alkanediamine, polymer with [(oxo-alkenyl)oxy]poly(oxy-alkanediyl)ether with 

bis(hydroxyalkyl)-alkanediol. 

P–19–0011A .. 7 10/16/2020 Shin etsu Silicones of 

America.

(G) Additive to the EPDM rubber compounds .... (G) Polysulfides, bis[3-(trialkoxysilyl)propyl]. 

P–19–0082A .. 4 10/06/2020 Bedoukian Research 

Inc.

(S) Fragrance uses per FFDCA: Fine fragrance, 

creams, lotions, etc, Fragrance uses per 

TSCA: Scented papers, candles, detergents, 

cleaners, etc.

(S) Heptanal, 6-hydroxy-2,6-dimethyl-. 

P–19–0167A .. 5 10/09/2020 Santolubes Manufacturing, LLC.(S) synthetic engine, gear and lubricating oils 

and greases.

(S) Poly(oxy-1,4-butanediyl), alpha-hydroomega-hydroxy-, hexanoate. 

P–20–0001A .. 5 10/09/2020 Santolubes Manufacturing, LLC.(S) Synthetic engine, gear & lubricating oils & 

greases.

(S) Poly(oxy-1,4-butanediyl), alpha-hydro-w-hydroxy-, nonanoate. 

P–20–0010A .. 10 10/14/2020 CBI .............................. (G) Polymerization auxiliary ................................ (G) Carboxylic acid, reaction products with 

metal hydroxide, inorganic dioxide and metal. 

P–20–0014A .. 2 10/06/2020 McTron Technologies (G) Water resistant resin additive, Heat resistant 

binder additive.

(G) Sugars, polymer with alkanetriamine. 

P–20–0046A .. 5 10/07/2020 CBI .............................. (G) Catalyst ......................................................... (G) Reaction products of alkyl-terminated 

alkylalumuminoxanes and {[(pentaalkylphenyl- 

(pentaalkylphenyl)amino)alkyl]alkanediaminato}bis(aralkyl) 

transition metal coordination compound. 

P–20–0046A .. 6 10/27/2020 CBI .............................. (G) Catalyst ......................................................... (G) Reaction products of alkyl-terminated 

alkylalumuminoxanes and {[(pentaalkylphenyl- 

(pentaalkylphenyl)amino)alkyl]alkanediaminato}bis(aralkyl) 

transition metal coordination compound. 

P–20–0048A .. 5 10/07/2020 CBI .............................. (G) Catalyst ......................................................... (G) Reaction products of alkyl-terminated 

alkylaluminoxanes and dihalogeno

(alkylcyclopentadienyl)

(tetraalkylcyclopentadienyl)transition metal coordination compound. 

Federal Register / Vol. 85, No. 241 / Tuesday, December 15, 2020 / Notices 81203 

TABLE I—PMN/SNUN/MCANS APPROVED * FROM 10/01/2020 TO 10/31/2020—Continued 

Case No. Version Received 

date Manufacturer Use Chemical substance 

P–20–0048A .. 6 10/27/2020 CBI .............................. (G) Catalyst ......................................................... (G) Reaction products of alkyl-terminated 

alkylaluminoxanes and dihalogeno

(alkylcyclopentadienyl)

(tetraalkylcyclopentadienyl)transition metal coordination compound. 

P–20–0049A .. 5 10/07/2020 CBI .............................. (G) Catalyst ......................................................... (G) Reaction products of alkyl-aluminoxanes 

and bis(alkylcyclodialkylene)

dihalogenozirconium. 

P–20–0049A .. 6 10/27/2020 CBI .............................. (G) Catalyst ......................................................... (G) Reaction products of alkyl-aluminoxanes 

and bis(alkylcyclodialkylene)

dihalogenozirconium. 

P–20–0061A .. 4 10/13/2020 Allnex USA Inc ........... (S) Coating resin crosslinking agent ................... (G) Formaldehyde, polymer with alkylphenols, 

alkyl ether. 

P–20–0085A .. 7 09/30/2020 Luna Innovations Incorporated.(S) Fluid resistant coatings ................................. (G) Bis(triethoxysilylpropyl carbamate) 

perfluoropolyether. 

P–20–0098A .. 4 10/21/2020 CBI .............................. (S) property modifier for polymers ...................... (G) Calcium cycloalkylcarboxylate. 

P–20–0102A .. 3 10/01/2020 Novihum Technologies, Inc.(S) Fertilizer/Soil amendment .............................. (S) Chemical Abstract (CA) index name: Coal, 

brown, ammoxidized. 

P–20–0102A .. 4 10/08/2020 Novihum Technologies, Inc.(S) Fertilizer/Soil amendment .............................. (S) Chemical Abstract (CA) index name: Coal, 

brown, ammoxidized. 

P–20–0118A .. 3 10/26/2020 CBI .............................. (G) Additive in household consumer products. ... (S) Pyridine, 4-methyl-2-pentylP–20–0138 ..... 3 10/14/2020 Gurit (USA) Inc ........... (S) The substance is part of a mixture with other 

amines to act as a curative for a 2-part epoxy 

adhesive formulation. The new substance will 

be used within an adhesive formulation for 

use within an industrial setting primarily but 

not limited to industries such as marine, automotive and wind energy. The adhesive is 

‘‘cured’’ at either ambient conditions or using 

heat and a chemical reaction occurs forming 

a solid composite structure.

(G) Alkane diglycidy ether, polymer with alkylcycloalkane diamines. 

P–20–0143A .. 3 10/22/2020 CBI .............................. (S) Binder for Thermoplastic Coatings, Binder or 

Ink/Adhesive.

(S) Cyclohexanemethanamine, 5-amino-1,3,3- 

trimethyl-, polymer with a-hydro-whydroxypoly(oxy-1,4-butanediyl), 5-isocyanato1-(isocyanatomethyl)-1,3,3- 

trimethylcyclohexane and 1,1-methylenebis[4- 

isocyanatobenzene]. 

P–20–0167A .. 3 10/22/2020 W.R. Grace & CO.— 

Conn.

(G) Catalyst ......................................................... (G) Phenylene, alkyl and polycarbomonocycle 

substituted, 1,2-dicarboxylate. 

P–20–0174A .. 4 10/16/2020 P2 Science, Inc .......... (S) For use in consumer products, as well as direct addition to consumer products. Specific 

functions would be as solubilizer, rheology 

modifier and fragrance oil.

(S) 6-Octen-1-ol, 3,7-dimethyl-, homopolymer, 

monoacetate. 

P–20–0184A .. 2 10/16/2020 P2 Science, Inc .......... (S) For use in fragrances for consumer products, as well as direct addition to consumer 

products. Specific functions would be as solubilizer, rheology modifier and fragrance oil.

(S) 6-Octen-1-ol, 3,7-dimethyl-, homopolymer. 

P–20–0185 ..... 3 10/08/2020 Designer Molecules, 

Inc.

(G) Dielectric film forming material for use in 

microelectronic assembly applications.

(S) Amines, C36-alkylenedi-, polymers with 

bicyclo[2.2.1]heptanedimethanamine, [5,5’- 

biisobenzofuran]-1,1’,3,3’-tetrone and 

3a,4,5,7a-tetrahydro-7-methyl-5-(tetrahydro2,5-dioxo-3-furanyl)-1,3-isobenzofurandione, 

maleated. 

P–21–0001 ..... 1 10/01/2020 CBI .............................. (G) Flame retardant ............................................. (S) Phosphinic acid, aluminum salt (3:1). 

P–21–0002 ..... 2 10/08/2020 CBI .............................. (G) Polymer in coatings and ink .......................... (G) Octadecanoic acid, 12-hydroxy-, polymer 

with aziridine, 2-oxepanone and tetrahydro2H-pyran-2-one, reaction products with 

disubstituted heteropolycycle. 

P–21–0006 ..... 1 10/21/2020 CBI .............................. (G) The PMN Substance is used in froth flotation to treat rare earth minerals and to remove 

deleterious substances.

(G) Naphthalene derivative. 

SN–19–0002A 6 10/14/2020 CBI .............................. (G) Friction and wear stabilizer in certain solid 

composite articles.

(G) Potassium Titanate. 

* The term ‘Approved’ indicates that a submission has passed a quick initial screen ensuring all required information and documents have been provided with the 

submission prior to the start of the 90-day review period, and in no-way reflects the final status of a complete submission review. 

In Table II of this unit, EPA provides 

the following information (to the extent 

that such information is not claimed as 

CBI) on the NOCs that have passed an 

initial screening by EPA during this 

period: The EPA case number assigned 

to the NOC including whether the 

submission was an initial or amended 

submission, the date the NOC was 

received by EPA, the date of 

commencement provided by the 

submitter in the NOC, a notation of the 

type of amendment (e.g., amendment to 

generic name, specific name, technical 

contact information, etc.) and chemical 

substance identity. 

81204 Federal Register / Vol. 85, No. 241 / Tuesday, December 15, 2020 / Notices 

TABLE II—NOCS APPROVED * FROM 10/01/2020 TO 10/31/2020 

Case No. Received 

date 

Commencement 

date 

If amendment, type of 

amendment Chemical substance 

P–16–0449 ........ 10/01/2020 09/28/2020 N ............................................ (S) 2,7-decadienal, (2e,7z)-. 

P–16–0539 ........ 10/07/2020 09/17/2020 N ............................................ (G) Organic sulfonate compound. 

P–18–0234A ...... 10/20/2020 12/09/2019 CBI Substantiation provided .. (G) Alkenoic acid, reaction products with bis substituted alkane and ether polyol. 

P–18–0310 ........ 10/20/2020 10/12/2020 N ............................................ (S) Benzenepropanoic acid, 3-(2h-benzotriazol-2-yl)-5-(1,1- 

dimethylethyl)-4-hydroxy-, 2,2-bis(hydroxymethyl)butyl 

ester. 

P–18–0359 ........ 10/20/2020 10/14/2020 N ............................................ (S) Ethene, 1-[difluoro(trifluoromethoxy)methoxy]-1,2,2- 

trifluoro-, polymer with 1,1-difluoroethene. 

P–18–0376 ........ 10/26/2020 10/15/2020 N ............................................ (G) Thiosulfuric acid, aminoalkyl ester. 

P–18–0382 ........ 10/20/2020 10/06/2020 N ............................................ (G) Xanthylium, bis[dicarboxycyclic]sulfonylaminoalkylcyclicamino-disulfo-sulfocyclic-, inner salt, 

monocationic salt. 

P–18–0393 ........ 10/23/2020 10/22/2020 N ............................................ (G) Alkenoic acid, alkyl, alkyl ester, polymer with alkyl 

propenoate, vinyl carbomonocyle, substituted alkyl 

propenoate, alkyl 2-alkyl 2-propenoate, alkanediol 

mono(2-alkyl-2-propenoate) and bicarbomonocylo alkyl 2- 

alkyl-2-alkenoate, tertiary alkyl substituted alkane 

peroxoate initiated. 

P–18–0405 ........ 09/29/2020 09/27/2020 N ............................................ (S) Phenol, 4,4’-(1-methylethylidene)bis-, polymer with 

3,6,9,12-tetraoxatetradeca-1,13-diene, glycidyl ether. 

P–20–0011 ........ 10/20/2020 10/12/2020 N ............................................ (G) Tetraoxaspiro[5.5]alkyl-3,9-diylbis(alkyl-2,1-diyl) bis(2- 

cyano-3-(3,4-dimethoxyphenyl)acrylate). 

P–20–0035 ........ 10/20/2020 10/06/2020 N ............................................ (G) Substituted aromatic, 3,3’-[[6-[(substituted alkyl amino)]- 

1,3,5-triazine-2,4-diyl]bis[imino[2-(substituted)-5-[substituted alkoxy]-4,1-phenylene]-2,1- 

diazenediyl]]bis[substituted, sodium salt]. 

P–20–0061 ........ 10/27/2020 10/25/2020 N ............................................ (G) Formaldehyde, polymer with alkylphenols, alkyl ether. 

P–20–0066 ........ 10/29/2020 10/29/2020 N ............................................ (G) 2-propenoic acid, 2-hydroxyethyl ester, reaction products with dialkyl hydrogen heterosubstituted phosphate 

and dimethyl phosphonate. 

* The term ‘Approved’ indicates that a submission has passed a quick initial screen ensuring all required information and documents have been 

provided with the submission. 

In Table III of this unit, EPA provides 

the following information (to the extent 

such information is not subject to a CBI 

claim) on the test information that has 

been received during this time period: 

The EPA case number assigned to the 

test information; the date the test 

information was received by EPA, the 

type of test information submitted, and 

chemical substance identity. 

TABLE III—TEST INFORMATION RECEIVED FROM 10/01/2020 TO 10/31/2020 

Case No. Received date Type of test information Chemical substance 

P–14–0712 ........ 10/02/2020 Quarterly PCDD/F Test of PMN Substance using 

EPA Test Method 8290A.

(G) Plastics, wastes, pyrolyzed, bulk pyrolysate. 

P–16–0543 ........ 10/13/2020 Exposure Monitoring Report ....................................... (G) Halogenophosphoric acid metal salt. 

P–17–0345 ........ 10/08/2020 Physical Chemical Properties Report (OECD Test 

Guideline 104 and 122; EC Methods A.9, A.14, 

A.15 and A.21), Acute Dermal Irritation (OECD 

Test Guideline 404), Acute Eye Irritation (OECD 

Test Guideline 405), Skin Sensitization, LLNA 

(OECD Test Guideline 422B), Acute Oral Toxicity 

(OECD Test Guideline 423), and Bacterial Reverse Mutation Assay (OECD Test Guideline 471).

(G) Polyurethane, methacrylate blocked. 

P–18–0154 ........ 10/12/2020 Algal Toxicity (OECD Test Guideline 201), Acute 

Oral Toxicity Study in Rats (OECD Test guideline 

423), and Water Extractability Study. All test submitted on analog data.

(G) Isocyanic acid, polyalkylenepolycycloalkylene 

ester, 2-alkoxy alkanol and 1-alkoxy alkanol and 

alkylene diol blocked. 

P–20–0066 ........ 09/29/2020 Reproductive/development Toxicity Screening Study 

in the Han Wistar Rat by Oral Gavage Administration.

(G) 2-propenoic acid, 2-hydroxyethyl ester, reaction 

products with dialkyl hydrogen heterosubstituted 

phosphate and dimethyl phosphonate. 

P–20–0162 ........ 10/07/2020 Acute Oral Toxicity Study in Rats (OCED Test 

Guideline 420) and Bacterial Reverse Mutation 

Test (Ames Assay, OECD Test Guideline 471).

(G) Substituted, triaryl-, 3-substituted-2-substituted 

alkyl tricycloalkane-1-carboxylate (1:1). 

P–20–0162 ........ 10/07/2020 Acute Oral Toxicity Study in Rats (OCED Test 

Guideline 420) and Bacterial Reverse Mutation 

Test (Ames Assay, OECD Test Guideline 471).

(G) Sulfonium, triaryl-, 3,3,3-trihalo-2-sulfoalkyl 

polycycloalkane-1-carboxylate (1:1). 

Federal Register / Vol. 85, No. 241 / Tuesday, December 15, 2020 / Notices 81205 

If you are interested in information 

that is not included in these tables, you 

may contact EPA’s technical 

information contact or general 

information contact as described under 

FOR FURTHER INFORMATION CONTACT to 

access additional non-CBI information 

that may be available. 

Authority: 15 U.S.C. 2601 et seq. 

Dated: November 12, 2020. 

Pamela Myrick, 

Director, Information Management Division, 

Office of Pollution Prevention and Toxics. 

[FR Doc. 2020–27540 Filed 12–14–20; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OGC–2020–0612; FRL 10017–99– 

OGC] 

Proposed Settlement Agreement; 

Biological Evaluations 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice of proposed settlement 

agreement; request for public comment. 

SUMMARY: In accordance with the 

Environmental Protection Agency (EPA) 

Administrator’s October 16, 2017, 

Directive Promoting Transparency and 

Public Participation in Consent Decrees 

and Settlement Agreements, notice is 

hereby given of a proposed settlement 

agreement in the five consolidated 

petitions for review in Center for 

Biological Diversity, et al. v. EPA (D.C. 

Cir. Nos. 15–1054, 15–1176, 15–1389, 

15–1462 and 16–1351) in the United 

States Court of Appeals for the District 

of Columbia. In 2015 and 2016, the 

Center for Biological Diversity and other 

Petitioners (collectively, ‘‘Petitioners’’) 

filed five petitions for review of 

registrations containing five active 

ingredients: flupyradifurone, 

bicyclopyrone, benzovindiflupyr, 

cuprous iodide, and haluaxifen-methyl. 

The five petitions for review alleged that 

EPA violated the Endangered Species 

Act (‘‘ESA’’) by failing to consult on the 

effects to listed species when registering 

products containing the five new active 

ingredients. The Court consolidated the 

cases on June 20, 2018. The registrants 

for each active ingredient other than 

cuprous iodide sought and were granted 

intervention. 

EPA, the Petitioners and the 

Defendant-Intervenors (collectively, 

‘‘the Parties’’) are proposing to enter 

into an out-of-court settlement 

agreement, which, among other things, 

calls for the Parties to file a Joint Motion 

for Order on Consent requesting that the 

Court order EPA to: complete a final 

effects determination for any use of 

cuprous iodide that is approved for sale 

and distribution by August 13, 2021; 

complete final Biological Evaluations 

for two of the other active ingredients by 

September 30, 2025 and the remaining 

two active ingredients by September 30, 

2027; and initiate consultation with the 

National Marine Fisheries Service and/ 

or the Fish and Wildlife Service 

(Services) as appropriate based on the 

outcome of the Biological Evaluations. 

DATES: Written comments on the 

proposed settlement agreement must be 

received by January 14, 2021. 

ADDRESSES: Submit your comments, 

identified by Docket ID number EPA– 

HQ–OGC–2020- 0612 online at 

www.regulations.gov (EPA’s preferred 

method). For comments submitted at 

www.regulations.gov, follow the online 

instructions for submitting comments. 

Once submitted, comments cannot be 

edited or removed from 

www.regulations.gov. The EPA may 

publish any comment received to its 

public docket. Do not submit 

electronically any information you 

consider to be Confidential Business 

Information (CBI) or other information 

whose disclosure is restricted by statute. 

Multimedia submissions (audio, video, 

etc.) must be accompanied by a written 

comment. The written comment is 

considered the official comment and 

should include discussion of all points 

you wish to make. The EPA generally 

will not consider comments or comment 

contents located outside of the primary 

submission (i.e. on the web, cloud, or 

other file sharing system). For 

additional submission methods, please 

contact the person identified in the FOR

FURTHER INFORMATION CONTACT section. 

For the full EPA public comment policy, 

information about CBI or multimedia 

submissions, and general guidance on 

making effective comments, please visit 

http://www2.epa.gov/dockets/ 

commenting-epa-dockets. 

FOR FURTHER INFORMATION CONTACT: Erin 

S. Koch, Pesticides and Toxic 

Substances Law Office (2333A), Office 

of General Counsel, U.S. Environmental 

Protection Agency, 1200 Pennsylvania 

Ave. NW, Washington, DC 20460; 

telephone: (202) 564–1718; email 

address: koch.erin@epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. Additional Information About the 

Proposed Settlement Agreement 

In 2015 and 2016, Petitioners filed 

five petitions for review in the Court of 

Appeals for the D.C. Circuit as EPA 

issued registrations for five new active 

ingredients, namely flupyradifurone, 

bicyclopyrone, benzovindiflupyr, 

cuprous iodide, and halauxifen-methyl. 

The petitions for review alleged that 

EPA violated Section 7(a)(2) of the ESA 

by failing to consult on the effects to 

listed species of the five new active 

ingredients. The Court consolidated the 

cases on June 20, 2018. The registrants 

for each active ingredient other than 

cuprous iodide sought and were granted 

intervention. 

The Parties have been engaged in 

settlement negotiations to reach an 

agreement in this case. The proposed 

settlement agreement between the 

Parties calls for, among other things, the 

Parties to file a Joint Motion for Order 

on Consent requesting that the Court 

order EPA to: (1) Complete a final 

effects determination for any use of 

cuprous iodide that is approved for sale 

and distribution by August 13, 2021; (2) 

complete final Biological Evaluations 

(BEs) for two of the other active 

ingredients by September 30, 2025 and 

the remaining two active ingredients by 

September 30, 2027; and (3) initiate 

consultation as appropriate based on the 

outcome of the BEs. 

Similar to the settlement agreement in 

CBD, et al. v. EPA, et al. (Case No. CV– 

11–0293–JCS (N.D. Cal.)), this proposed 

settlement agreement provides for the 

possibility of extending these dates if 

specific events occur, such as an 

extension of a comment period. 

In addition to the commitments 

above, the settlement agreement 

provides that within three months of 

issuance of draft BEs or no later than 

December of 2024 and 2026, the Parties 

will meet and discuss potential interim 

measures. The settlement agreement 

also provides that EPA will maintain a 

web page that includes the settlement 

agreement, associated court orders, and 

a link to an independent 3rd-party web 

page hosted, maintained, and funded by 

Defendant-Intervenors. 

For a period of thirty (30) days 

following the date of publication of this 

notice, the Agency will accept written 

comments relating to the proposed 

settlement agreement from persons who 

are not named as parties to the litigation 

in question. EPA may withdraw or 

withhold consent to the proposed 

settlement if the comments disclose 

facts or considerations that indicate that 

such consent is inappropriate, 

improper, inadequate, or inconsistent 

with the requirements of the ESA or the 

Federal Insecticide, Fungicide, and 

Rodenticide Act. Unless EPA 

determines that consent should be 

withdrawn, the terms of the proposed 

settlement agreement will be affirmed.